1
|
Scorilas A, Kyriakopoulou L, Yousef GM,
Ashworth LK, Kwamie A and Diamandis EP: Molecular cloning, physical
mapping, and expression analysis of a novel gene, BCL2L12, encoding
a proline-rich protein with a highly conserved BH2 domain of the
Bcl-2 family. Genomics. 72:217–221. 2001. View Article : Google Scholar
|
2
|
Stegh AH, Brennan C, Mahoney JA, Forloney
KL, Jenq HT, Luciano JP, Protopopov A, Chin L and Depinho RA:
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor. Genes
Dev. 24:2194–2204. 2010. View Article : Google Scholar
|
3
|
Tzovaras A, Kladi-Skandali A, Michaelidou
K, Zografos GC, Missitzis I, Ardavanis A and Scorilas A: BCL2L12: A
promising molecular prognostic biomarker in breast cancer. Clin
Biochem. 47:257–262. 2014. View Article : Google Scholar
|
4
|
Stegh AH, Kim H, Bachoo RM, Forloney KL,
Zhang J, Schulze H, Park K, Hannon GJ, Yuan J, Louis DN, et al:
Bcl2L12 inhibits post-mitochondrial apoptosis signaling in
glioblastoma. Genes Dev. 21:98–111. 2007. View Article : Google Scholar
|
5
|
Stegh AH, Kesari S, Mahoney JE, Jenq HT,
Forloney KL, Protopopov A, Louis DN, Chin L and DePinho RA:
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via
distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA.
105:10703–10708. 2008. View Article : Google Scholar
|
6
|
Jensen SA, Day ES, Ko CH, Hurley LA,
Luciano JP, Kouri FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI, et
al: Spherical nucleic acid nanoparticle conjugates as an RNAi-based
therapy for glioblastoma. Sci Transl Med. 5:209ra1522013.
View Article : Google Scholar
|
7
|
Chou CH, Chou AK, Lin CC, Chen WJ, Wei CC,
Yang MC, Hsu CM, Lung FW, Loh JK, Howng SL and Hong YR: GSK3β
regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in
glioblastoma and is inhibited by LiCl. Cell Cycle. 11:532–542.
2012. View Article : Google Scholar
|
8
|
Kontos CK and Scorilas A: Molecular
cloning of novel alternatively spliced variants of BCL2L12, a new
member of the BCL2 gene family, and their expression analysis in
cancer cells. Gene. 505:153–166. 2012. View Article : Google Scholar
|
9
|
Yang MC, Loh JK, Li YY, Huang WS, Chou CH,
Cheng JT, Wang YT, Lieu AS, Howng SL, Hong YR and Chou AK: Bcl2L12
with a BH3-like domain in regulating apoptosis and TMZ-induced
autophagy: A prospective combination of ABT-737 and TMZ for
treating glioma. Int J Oncol. 46:1304–1316. 2015. View Article : Google Scholar
|
10
|
Blough MD, Beauchamp DC, Westgate MR,
Kelly JJ and Cairncross JG: Effect of aberrant p53 function on
temozolomide sensitivity of glioma cell lines and brain tumor
initiating cells from glioblastoma. J Neurooncol. 102:1–7. 2011.
View Article : Google Scholar
|
11
|
Srivastava A, Jain A, Jha P, Suri V,
Sharma MC, Mallick S, Puri T, Gupta DK, Gupta A and Sarkar C: MGMT
gene promoter methylation in pediatric glioblastomas. Childs Nerv
Syst. 26:1613–1618. 2010. View Article : Google Scholar
|
12
|
Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH,
Lin YF and Shih CM: Resveratrol enhances the therapeutic effect of
temozolomide against malignant glioma in vitro and in vivo by
inhibiting autophagy. Free Radic Biol Med. 52:377–391. 2012.
View Article : Google Scholar
|
13
|
Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH,
Chen TH and Shih CM: Inhibition of mitochondria- and endoplasmic
reticulum stress-mediated autophagy augments temozolomide-induced
apoptosis in glioma cells. PLoS One. 7:e387062012. View Article : Google Scholar
|
14
|
Behrends C, Sowa ME, Gygi SP and Harper
JW: Network organization of the human autophagy system. Nature.
466:68–76. 2010. View Article : Google Scholar
|
15
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar
|
16
|
Sinha S and Levine B: The autophagy
effector Beclin 1: A novel BH3-only protein. Oncogene. 27(Suppl 1):
S137–S148. 2008. View Article : Google Scholar
|
17
|
Kim SY, Song X, Zhang L, Bartlett DL and
Lee YJ: Role of Bcl-xL/Beclin-1 in interplay between apoptosis and
autophagy in oxaliplatin and bortezomib-induced cell death. Biochem
Pharmacol. 88:178–188. 2014. View Article : Google Scholar
|
18
|
Fields S and Song O: A novel genetic
system to detect protein-protein interactions. Nature. 340:245–246.
1989. View Article : Google Scholar
|
19
|
Chien CT, Bartel PL, Sternglanz R and
Fields S: The two-hybrid system: A method to identify and clone
genes for proteins that interact with a protein of interest. Proc
Natl Acad Sci USA. 88:9578–9582. 1991. View Article : Google Scholar
|
20
|
Zhu L: Yeast GAL4 two-hybrid system. A
genetic system to identify proteins that interact with a target
protein. Methods Mol Biol. 63:173–196. 1997.
|
21
|
Homeyer N, Horn AH, Lanig H and Sticht H:
AMBER force-field parameters for phosphorylated amino acids in
different protonation states: Phosphoserine, phosphothreonine,
phosphotyrosine, and phosphohistidine. J Mol Model. 12:281–289.
2006. View Article : Google Scholar
|
22
|
Ryckaert JP, Ciccotti G and Berendsen HJC:
Numerical integration of the cartesian equations of motion of a
system with constraints: Molecular dynamics of n-alkanes. J Comput
Phys. 23:327–341. 1977. View Article : Google Scholar
|
23
|
Darden T, York D and Pedersen L: Particle
mesh Ewald: An N [center-dot] log(N) method for Ewald sums in large
systems. J Chem Phys. 98:10089–10092. 1993. View Article : Google Scholar
|
24
|
Chahal M, Xu Y, Lesniak D, Graham K,
Famulski K, Christensen JG, Aghi M, Jacques A, Murray D, Sabri S
and Abdulkarim B: MGMT modulates glioblastoma angiogenesis and
response to the tyrosine kinase inhibitor sunitinib. Neuro Oncol.
12:822–833. 2010. View Article : Google Scholar
|
25
|
Malley DS, Hamoudi RA, Kocialkowski S,
Pearson DM, Collins VP and Ichimura K: A distinct region of the
MGMT CpG island critical for transcriptional regulation is
preferentially methylated in glioblastoma cells and xenografts.
Acta Neuropathol. 121:651–661. 2011. View Article : Google Scholar
|
26
|
Stegh AH and DePinho RA: Beyond effector
caspase inhibition: Bcl2L12 neutralizes p53 signaling in
glioblastoma. Cell Cycle. 10:33–38. 2011. View Article : Google Scholar
|
27
|
Tang JB, Svilar D, Trivedi RN, Wang XH,
Goellne EM, Moore B, Hamilton RL, Banze LA, Brown AR and Sobol RW:
N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER
inhibitor potentiation of glioma cells to temozolomide. Neuro
Oncol. 13:471–486. 2011. View Article : Google Scholar
|
28
|
Hermisson M, Klumpp A, Wick W, Wischhusen
J, Nagel G, Roos W, Kaina B and Weller M: O6-methylguanine DNA
meth-yltransferase and p53 status predict temozolomide sensitivity
in human malignant glioma cells. J Neurochem. 96:766–776. 2006.
View Article : Google Scholar
|
29
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar
|
30
|
Jia W, Jiang X, Liu W, Wang L, Zhu B, Zhu
H, Liu X, Zhong M, Xie D, Huang W, et al: Effects of
three-dimensional collagen scaffolds on the expression profiles and
biological functions of glioma cells. Int J Oncol. Mar 20–2018.Epub
ahead of print. View Article : Google Scholar
|
31
|
Hong Y, Yang J, Wu W, Wang W, Kong X, Wang
Y, Yun X, Zong H, Wei Y, Zhang S and Gu J: Knockdown of BCL2L12
leads to cisplatin resistance in MDA-MB-231 breast cancer cells.
Biochim Biophys Acta. 1782:649–657. 2008. View Article : Google Scholar
|
32
|
Adamopoulos PG, Kontos CK, Tsiakanikas P
and Scorilas A: Identification of novel alternative splice variants
of the BCL2L12 gene in human cancer cells using next-generation
sequencing methodology. Cancer Lett. 373:119–129. 2016. View Article : Google Scholar
|
33
|
Cheng EH, Wei MC, Weiler S, Flavell RA,
Mak TW, Lindsten T and Korsmeyer SJ: BCL-2, BCL-X(L) sequester BH3
domain-only molecules preventing BAX- and BAK-mediated
mitochondrial apoptosis. Mol Cell. 8:705–711. 2001. View Article : Google Scholar
|
34
|
Lomonosova E and Chinnadurai G: BH3-only
proteins in apop-tosis and beyond: An overview. Oncogene. 27(Suppl
1): S2–S19. 2008. View Article : Google Scholar
|
35
|
Di Rita A and Strappazzon F: AMBRA1, a
Novel BH3-like protein: New insights into the AMBRA1-BCL2-family
proteins relationship. Int Rev Cell Mol Biol. 330:85–113. 2017.
View Article : Google Scholar
|
36
|
Song DD, Zhang TT, Chen JL, Xia YF, Qin
ZH, Waeber C and Sheng R: Sphingosine kinase 2 activates autophagy
and protects neurons against ischemic injury through interaction
with Bcl-2 via its putative BH3 domain. Cell Death Dis.
8:e29122017. View Article : Google Scholar
|
37
|
Zeng X, Overmeyer JH and Maltese WA:
Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase
complex in macroautophagy versus endocytosis and lysosomal enzyme
trafficking. J Cell Sci. 119:259–270. 2006. View Article : Google Scholar
|
38
|
Liang C, Lee JS, Inn KS, Gack MU, Li Q,
Roberts EA, Vergne I, Deretic V, Feng P, Akazawa C and Jung JU:
Beclin1-binding UVRAG targets the class C Vps complex to coordinate
autophagosome maturation and endocytic trafficking. Nat Cell Biol.
10:776–787. 2008. View Article : Google Scholar
|
39
|
Stegh AH, Chin L, Louis DN and DePinho RA:
What drives intense apoptosis resistance and propensity for
necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional
cell death regulator. Cell Cycle. 7:2833–2839. 2008. View Article : Google Scholar
|
40
|
Kouri FM, Ritner C and Stegh AH: miRNA-182
and the regulation of the glioblastoma phenotype-toward miRNA-based
precision therapeutics. Cell Cycle. 14:3794–3800. 2015. View Article : Google Scholar
|
41
|
van Delft MF, Wei AH, Mason KD, Vandenberg
CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, et
al: The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and
efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
Cancer Cell. 10:389–399. 2006. View Article : Google Scholar
|
42
|
Pedro JM, Wei Y, Sica V, Maiuri MC, Zou Z,
Kroemer G and Levine B: BAX and BAK1 are dispensable for
ABT-737-induced dissociation of the BCL2-BECN1 complex and
autophagy. Autophagy. 11:452–459. 2015. View Article : Google Scholar :
|